HELX holdings

All 63 positions of Franklin Genomic Advancements ETF.

Download CSV

Positions

Top 10 weight

47.1%

Effective holdings

28.3

1 / sum of squared weights

In stocks

98.7%

In bonds

0.0%

Outside the US

12.1%

Asset mix

Equity97.9%
Preferred0.8%

Sectors

89% of stocks classified

Health Care80.2%
Technology5.8%
Consumer Staples2.3%

Countries

United States86.6%
United Kingdom3.0%
South Korea2.6%
Germany2.2%
Netherlands2.1%
Switzerland1.2%
Ireland0.8%
Singapore0.1%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	GHGuardant Health, Inc. Common Stock	Equity	9.09%	$2.5M	16,927	US
2	NTRANatera, Inc. Common Stock	Equity	7.46%	$2.1M	7,679	US
3	KRYSKrystal Biotech, Inc. Common Stock	Equity	6.33%	$1.8M	4,757	US
4	LGNDLigand Pharmaceuticals Inc.	Equity	4.62%	$1.3M	4,085	US
5	ADPTAdaptive Biotechnologies Corporation Common Stock	Equity	3.99%	$1.1M	51,956	US
6	UTHRUnited Therapeutics Corp	Equity	3.51%	$980K	1,809	US
7	BBIOBridgeBio Pharma, Inc. Common Stock	Equity	3.50%	$978K	13,129	US
8	LLYEli Lilly & Co.	Equity	2.95%	$825K	688	US
9	TWSTTwist Bioscience Corporation Common Stock	Equity	2.85%	$796K	7,736	US
10	VRTXVertex Pharmaceuticals Inc	Equity	2.75%	$767K	1,545	US
11	ASTRAZENECA PLC	Equity	2.70%	$754K	3,979	GB
12	TVTXTravere Therapeutics, Inc. Common Stock	Equity	2.59%	$724K	12,753	US
13	INSMInsmed, Inc.	Equity	2.44%	$681K	6,388	US
14	SAMSUNG BIOLOGICS CO LTD	Equity	2.26%	$630K	702	KR
15	CTVACorteva, Inc. Common Stock	Equity	2.25%	$630K	7,435	US
16	MEDPMedpace Holdings, Inc. Common Stock	Equity	2.15%	$600K	1,133	US
17	ALNYAlnylam Pharmaceuticals, Inc.	Equity	1.96%	$547K	1,816	US
18	TEMTempus AI, Inc. Class A Common Stock	Equity	1.95%	$544K	9,397	US
19	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	1.91%	$534K	6,739	US
20	NBIXNeurocrine Biosciences Inc	Equity	1.84%	$515K	3,058	US
21	REGNRegeneron Pharmaceuticals Inc	Equity	1.80%	$502K	805	US
22	VCYTVeracyte, Inc.	Equity	1.64%	$459K	7,819	US
23	ARGENX SE	Equity	1.64%	$458K	494	NL
24	PTCTPTC Therapeutics, Inc.	Equity	1.46%	$409K	5,009	US
25	BNTXBioNTech SE American Depositary Share	Equity	1.38%	$387K	4,156	DE
26	STOKStoke Therapeutics, Inc. Common Stock	Equity	1.33%	$371K	11,349	US
27	CRLCharles River Laboratories International, Inc.	Equity	1.26%	$353K	1,556	US
28	GRALGRAIL, Inc. Common Stock	Equity	1.09%	$304K	4,456	US
29	ANABAnaptysBio, Inc. Common Stock	Equity	1.04%	$290K	4,290	US
30	CRISPR THERAPEUTICS AG	Equity	0.98%	$274K	5,030	CH
31	RGENRepligen Corp	Equity	0.98%	$274K	2,009	US
32	CDNSCadence Design Systems	Equity	0.97%	$272K	725	US
33	BEAMBeam Therapeutics Inc. Common Stock	Equity	0.93%	$260K	7,577	US
34	PRAXPraxis Precision Medicines, Inc. Common Stock	Equity	0.86%	$240K	718	US
35	SARTORIUS AG	Preferred	0.85%	$238K	905	DE
36	AXSMAxsome Therapeutics, Inc	Equity	0.82%	$229K	936	US
37	CDNACareDx, Inc.	Equity	0.82%	$228K	8,000	US
38	JAZZ PHARMACEUTICALS PLC	Equity	0.78%	$218K	905	IE
39	CPRXCatalyst Pharmaceutical Inc.	Equity	0.77%	$216K	6,865	US
40	TMOThermo Fisher Scientific, Inc.	Equity	0.76%	$211K	421	US
41	IQVIQVIA Holdings Inc.	Equity	0.75%	$209K	1,082	US
42	HNGEHinge Health, Inc.	Equity	0.70%	$195K	2,349	US
43	RAREUltragenyx Pharmaceutical Inc.	Equity	0.61%	$171K	5,131	US
44	AAgilent Technologies Inc.	Equity	0.58%	$162K	1,223	US
45	DHRDanaher Corporation	Equity	0.57%	$160K	842	US
46	QIAGEN NV	Equity	0.48%	$134K	3,419	NL
47	RYTMRhythm Pharmaceuticals, Inc. Common Stock	Equity	0.42%	$116K	1,048	US
48	ARQTArcutis Biotherapeutics, Inc. Common Stock	Equity	0.42%	$116K	4,422	US
49	SAMSUNG EPIS HOLDINGS CO LTD	Equity	0.37%	$104K	376	KR
50	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	Equity	0.34%	$95K	1,479	GB
51	TARSTarsus Pharmaceuticals, Inc. Common Stock	Equity	0.26%	$71K	1,136	US
52	BIOBio-Rad Laboratories, Inc.Class A	Equity	0.26%	$71K	243	US
53	LQDALiquidia Corporation Common Stock	Equity	0.25%	$69K	871	US
54	BMYBristol-Myers Squibb Co.	Equity	0.25%	$69K	1,196	US
55	TGTXTG Therapeutics, Inc.	Equity	0.25%	$69K	1,253	US
56	ONCBeOne Medicines Ltd. American Depositary Shares	Equity	0.23%	$64K	225	CH
57	NGNENeurogene, Inc. Common Stock	Equity	0.22%	$62K	1,981	US
58	TRAXFirst Tracks Biotherapeutics, Inc. Ordinary Shares	Equity	0.20%	$56K	2,775	US
59	WGSGeneDx Holdings Corp. Class A Common Stock	Equity	0.14%	$39K	575	US
60	WAVE LIFE SCIENCES LTD	Equity	0.10%	$28K	4,813	SG
61	RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	Equity	0.07%	$20K	5,507	US
62	OABIWOmniAb, Inc. Warrant	Equity	0.00%	$0	240	US
63	OABIWOmniAb, Inc. Warrant	Equity	0.00%	$0	240	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Increase	TVTXTRAVERE THERAPEUTICS INC	1.40%	2.59%	+16.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	MEDPMEDPACE HOLDINGS INC	2.97%	2.15%	−20.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ANABANAPTYSBIO INC	0.53%	1.04%	+95.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	BNTXBIONTECH SE	1.80%	1.38%	−11.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	AXSMAXSOME THERAPEUTICS INC	0.45%	0.82%	+53.6%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	DHRDANAHER CORP	0.93%	0.57%	−25.5%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	—	0.34%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	WGSGENEDX HOLDINGS CORP	0.42%	0.14%	−62.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CDNSCADENCE DESIGN SYSTEMS INC	0.71%	0.97%	+23.5%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	LQDALIQUIDIA CORP	—	0.25%	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	TGTXTG THERAPEUTICS INC	—	0.25%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	TARSTARSUS PHARMACEUTICALS INC	0.49%	0.26%	−29.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	TMDXTransMedics Group Inc.	0.22%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	TRAXFIRST TRACKS BIOTHERAPEUTICS INC	—	0.20%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	RXRXRECURSION PHARMACEUTICALS INC	0.15%	0.07%	−50.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	CAICaris Life Sciences Inc.	0.05%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	AstraZeneca PLC	—	3.40%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	AZNAstraZeneca PLC	2.80%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	EXASExact Sciences Corp	2.27%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	WGSGeneDx Holdings Corp	2.28%	0.42%	−65.9%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	MEDPMedpace Holdings Inc.	4.41%	2.97%	−28.3%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	ALNYAlnylam Pharmaceuticals Inc.	3.62%	2.60%	−21.4%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	STOKStoke Therapeutics Inc	0.83%	1.60%	+70.2%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	TWSTTwist Bioscience Corporation	0.88%	1.59%	+10.2%	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	QIAGEN NV	0.64%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	PRAXPraxis Precision Medicines Inc	0.39%	1.00%	+113.1%	Dec 31, 2025 → Mar 31, 2026 SEC
New position	QIAGEN NV	—	0.59%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	DOCSDoximity Inc	0.55%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	ANABAnaptysBio Inc.	—	0.53%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	TARSTarsus Pharmaceuticals Inc	—	0.49%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	CRISPR Therapeutics AG	0.70%	1.04%	+47.5%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	CAICaris Life Sciences Inc.	0.23%	0.05%	−72.8%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	CPRXCatalyst Pharmaceuticals Inc.	0.55%	0.74%	+15.0%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	RXRXRecursion Pharmaceuticals Inc	0.30%	0.15%	−40.6%	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	DVAXDynavax Technologies Corp	0.14%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	BMYBristol-Myers Squibb Company	0.17%	0.31%	+46.1%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	RAREUltragenyx Pharmaceuticals Inc	0.57%	0.47%	−18.7%	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	SDGRSchrodinger Inc/United States	0.10%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.